1.Directly prevents HIV from infecting CD4 T T-cells 2.Activates the Th1 immune response, i.e., turns on macrophages that actually ingest HIV itself, killer T actually T-lymphocytes that destroy HIV HIV-infected cells and other HIV cells HIV-fighting immune system responses Currently it’s the only HIV/AIDS therapy to achieve this.
MODE 1 By binding to specific proteins onthe outer surface of HIV particles,Immunotech IPF directly prevents HIV from infecting CD4 T T-cells.
• HIV gp120 binds to CD4 on TT-cells and then to a coreceptor. • Causes gp41 attachment to the cell membrane = virus-cell fusion and HIV infection. • IPF inactivates gp120 and gp41 =no HIV binding to cells and no HIV infection. MODE 2 Immunotech IPF binds to T-cells and turns on Th1 immune system responses that kill HIV and HIV- infected cells. Not done by any other HIV/AIDS therapies.
IFN-?,IL-2 and TNF-? are cytokines, small proteins released by T-cells and received by other cells to generate a specific immune response.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.